CVSI

CV Sciences earns a Neutral rating with a 44.2 composite score and low conviction of 2/5. Fundamentals provide the strongest pillar at 50.0, supported primarily by the 49.8% gross margin, whose subscore of 82.9 leads the assessment, and an operating-margin subscore of 69.3. Regulatory follows closely at 49.0, reflecting a balanced US jurisdiction posture and no recorded enforcement hits, though filing cadence limits the contribution. Market scores 40.0 because no quote is available from institutional pricing feeds, while editorial ranks last at 30.0 amid no recent newsroom or brief activity in CIN newsroom coverage. The resulting mix places the shares squarely in the Neutral band rather than establishing a directional case.

Licensed fundamentals data show year-over-year revenue contraction of 11.4%, offset partly by a gross margin just below 50%. That product-level profitability has not carried through the cost structure: the operating margin remains negative at roughly 10%, EBITDA stands at a $666,000 loss, and net income records a $1.49 million loss. The approximately $4.08 million market capitalization receives no support from the size-tier subscore, reinforcing limited financial scale. A 0.163 cash-burn ratio and a 52.0 cash-runway subscore provide some fundamental credit, but the stated financial condition remains stretched. Primary regulatory filings show no captured latest filing date, while the cadence subscore is only 25.0. No regulatory events appear across either the 90-day or 180-day windows, and no enforcement hits bolster the regulatory pillar’s 80.0 enforcement subscore.

The principal forward catalyst sits within fundamentals, the highest-scoring pillar. Gross margin already supplies the clearest operating strength, but a higher valuation case requires that margin to convert into improved operating economics while revenue stabilizes. Renewed top-line growth would raise the weakest major fundamentals input and give the existing gross-profit profile greater leverage against fixed costs. Better filing regularity could add secondary support, while fresh CIN newsroom coverage could improve the lowest pillar, but neither carries the same scoring influence as a fundamental turn. The single most important signal to watch is a return to positive year-over-year revenue growth accompanied by a narrower operating loss.